Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial

NCT04712279 is registered in ClinicalTrials.gov with Corpometria Institute as lead sponsor.

NCT NCT04712279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04712279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial
Lead sponsor
Corpometria Institute
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 25, 2021
Completion date
April 20, 2021
Enrollment
294 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19